Mitra Miri
Principal at Osage University Partners
Cambridge, Massachusetts
Overview
Work Experience
Board Observer
2022 - Current
Precede Biosciences is breaking down the barriers to precision medicine by redefining what can be gleaned from a simple blood draw.
Raised $57,000,000.00 from Illumina Ventures, OUP (Osage University Partners), Bristol-Myers Squibb, Lilly Asia Ventures, Qatar Investment Authority, Binney Street Capital and 5AM Ventures.
Principal
2022
Senior Investment Associate
2021 - 2022
OUP is a venture capital fund investing in start-ups that commercialize university research.
Board Observer
2021
Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.
Raised $65,000,000.00 from Sanofi Ventures, Taiho Ventures, OUP (Osage University Partners) and Canaan Partners.
Investment Associate
2020 - 2021
Life Sciences Consultant (Project Leader), Healthcare Practice
2018 - 2020
Blavatnik Associate
2017 - 2018
Business Analyst, Office of the Provost (David Swensen Fellow)
2016 - 2018
Canaan Partners Venture Fellow
2016 - 2017
Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.
Flagship Pioneering VentureLabs Fellow
2016 - 2016
Flagship Pioneering is a venture capital firm that invests in life sciences and healthcare companies.
Rotary Ambassadorial Fellow
2008 - 2009
Established IDI’s first translational lab in collaboration with the Dir. of Research and built capacity to conduct >600 assays/month; initiated projects to develop & evaluate the cost-benefit of TB diagnostic tools for resource-limited settings